Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FNP8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,722
Award facts
- Contract value 100% obligated
- $36,721.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $36,721.62 for Enbrel 50 mg/mL SureClick auto-injector medication. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency procures medical supplies for military healthcare systems, including the Defense Health Agency and other federal health programs. AmerisourceBergen's role as a pharmaceutical prime vendor reflects its critical position in the federal medical supply chain, delivering both brand-name and generic medications across multiple therapeutic domains. The award includes no set-aside designation, indicating it was awarded through open competition. This delivery order for Enbrel, a rheumatoid arthritis treatment, exemplifies the company's extensive portfolio of specialty medications and auto-injector devices supporting federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FNP8Q?
SPE2DR26FNP8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FNP8Q worth?
The government has obligated $36,722 on SPE2DR26FNP8Q.
Is contract SPE2DR26FNP8Q an order under another contract?
Yes. SPE2DR26FNP8Q is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNP8Q competed?
The extent of competition for SPE2DR26FNP8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award